Global Snoring Control Devices Market 2017-2021
SKU ID :TNV-10359487 | Published Date: 13-Mar-2017 | No. of pages: 70Description
TOC
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
• Key market highlights
PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 06: Market segmentation by product
• MADs
• TSDs
• Nasal devices
• Chin straps
• EPAP
• Others
PART 07: Market segmentation by end-user
• Hospitals
• Sleep labs
• Home-care settings
PART 08: Geographical segmentation
• Snoring control devices market in Americas
• Snoring control devices market in EMEA
• Snoring control devices market in APAC
PART 09: Decision framework
PART 10: Drivers and challenges
• Market drivers
• Impact of drivers on key customer segments
• Market challenges
• Impact of challenges on key customer segments
PART 11: Market trends
• Use of 3D printing technology in the production of snoring control devices
• Growing focus toward online promotional and marketing strategies
• Integration of mobile devices with home healthcare systems
PART 12: Vendor landscape
• Competitive landscape analysis
PART 13: Key vendor analysis
• GlaxoSmithKline
• MPowrx Health and Wellness Products
• ResMed
• Other prominent vendors
PART 14: Appendix
• List of abbreviations
List of Exhibits
Exhibit 01: Market overview: Global snoring control devices
Exhibit 02: Global snoring control devices market 2016-2021 ($ billions)
Exhibit 03: Five forces analysis
Exhibit 04: Global snoring control devices market segmentation by product 2016
Exhibit 05: Global MADs market 2016-2021: Market overview
Exhibit 06: Key product offerings: MADs
Exhibit 07: Global MADs market 2016-2021 ($ billions)
Exhibit 08: Global TSDs market 2016-2021: Market overview
Exhibit 09: Key product offerings: TSDs
Exhibit 10: Global TSDs market 2016-2021 ($ billions)
Exhibit 11: Global nasal devices market 2016-2021: Market overview
Exhibit 12: Key product offerings: Nasal devices
Exhibit 13: Global nasal devices market 2016-2021 ($ billions)
Exhibit 14: Global chin straps market 2016-2021: Market overview
Exhibit 15: Key product offerings: Chin straps
Exhibit 16: Global chin straps market 2016-2021 ($ billions)
Exhibit 17: Global EPAP market 2016-2021: Market overview
Exhibit 18: Key product offerings: EPAP
Exhibit 19: Global EPAP market 2016-2021 ($ billions)
Exhibit 20: Global other snoring control devices market 2016-2021 ($ billions)
Exhibit 21: Global snoring control devices market by end-user 2016 (%)
Exhibit 22: Global snoring control devices market by geographical segmentation 2016 (%)
Exhibit 23: Market overview: Snoring control devices market in Americas
Exhibit 24: Snoring control devices market in Americas 2016-2021 ($ billions)
Exhibit 25: Market overview: Snoring control devices market in EMEA
Exhibit 26: Snoring control devices market in EMEA 2016-2021 ($ billions)
Exhibit 27: Market overview: Snoring control devices market in APAC
Exhibit 28: Snoring control devices market in APAC 2016-2021 ($ billions)
Exhibit 29: Impact of drivers
Exhibit 30: Cost of surgical procedures
Exhibit 31: Impact of challenges
Exhibit 32: Competitive structure analysis of global snoring control devices market 2016
Exhibit 33: Competitive landscape analysis of global snoring control devices market 2016
Exhibit 34: Strategic factors determining success for leading companies in global snoring control devices market
Exhibit 35: GlaxoSmithKline: Key highlights
Exhibit 36: GlaxoSmithKline: Strength assessment
Exhibit 37: GlaxoSmithKline: Strategy assessment
Exhibit 38: GlaxoSmithKline: Opportunity assessment
Exhibit 39: MPowrx Health and Wellness Products: Key highlights
Exhibit 40: MPowrx Health and Wellness Products: Strength assessment
Exhibit 41: MPowrx Health and Wellness Products: Strategy assessment
Exhibit 42: MPowrx Health and Wellness Products: Opportunity assessment
Exhibit 43: ResMed: Key highlights
Exhibit 44: ResMed: Strength assessment
Exhibit 45: ResMed: Strategy assessment
Exhibit 46: ResMed: Opportunity assessment
Exhibit 47: Other prominent vendors
Tables & Figures
Companies
GlaxoSmithKline, MPowrx Health and Wellness Products, ResMed, AirSnore, Apnea Sciences, MEDiTAS, Sleeping Well, SleepTight Mouthpiece, SNOREDOC, SnoreMeds, TheraSnore, VitalSleep, and ZYPPAH.
- PRICE
-
$2500$4000